Two recent epidemiology studies demonstrate that testosterone replacement therapy drugs (“Low-T drugs”) are causing heart attacks, strokes and blood clot injuries in some male users. Low-T drugs include Androgel, Androderm, Axirom, Bio-T-Gel, Delatestryl, Depo-Testosterone, Fortesta, Striant, Testim, and Testopel. Since the beginning of 2014, the United States Food and Drug Administration has warned on two separate occasions that testosterone products may be associated with an increased risk of heart attack, stroke, pulmonary embolism, deep venous thrombosis and sudden death. The FDA has also warned patients that testosterone is being used extensively “off-label” to offset the natural aging process in men when the medications are not approved and show no benefit for this purpose. The FDA’s recent warnings have not stopped the manufacturers of Low-T medications from spending hundreds of millions of dollars each year marketing the drugs. As more and more baby boomers begin to use testosterone replacement therapies, sales of Low-T drugs are expected to hit $5 billion annually by 2017. With the number of new users skyrocketing, we expect the numbers of heart attacks and strokes associated with the medications to also increase substantially Contact Lewis Saul & Associates, P.C. To Discuss Your Rights If you or a loved one used a testosterone replacement therapy product and suffered a heart attack, stroke, pulmonary embolism, deep venous thrombosis, death or other cardiovascular injury, you may be entitled to pursue a claim against the manufacturers for damages. For a free and confidential case evaluation, please call our office toll-free at (888) 747-5342 or complete our online contact form and we will promptly respond to your inquiry.